123 related articles for article (PubMed ID: 32540764)
21. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent.
Ngernyuang N; Seubwai W; Daduang S; Boonsiri P; Limpaiboon T; Daduang J
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():411-415. PubMed ID: 26706547
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells).
Kumar CS; Raja MD; Sundar DS; Gover Antoniraj M; Ruckmani K
Carbohydr Polym; 2015 Sep; 128():63-74. PubMed ID: 26005140
[TBL] [Abstract][Full Text] [Related]
23. Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
Danesh NM; Lavaee P; Ramezani M; Abnous K; Taghdisi SM
Int J Pharm; 2015 Jul; 489(1-2):311-7. PubMed ID: 25936625
[TBL] [Abstract][Full Text] [Related]
24. A Nanotechnology-based Strategy to Increase the Efficiency of Cancer Diagnosis and Therapy: Folate-conjugated Gold Nanoparticles.
Beik J; Khademi S; Attaran N; Sarkar S; Shakeri-Zadeh A; Ghaznavi H; Ghadiri H
Curr Med Chem; 2017; 24(39):4399-4416. PubMed ID: 28799495
[TBL] [Abstract][Full Text] [Related]
25. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement.
Beik J; Jafariyan M; Montazerabadi A; Ghadimi-Daresajini A; Tarighi P; Mahmoudabadi A; Ghaznavi H; Shakeri-Zadeh A
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1993-2001. PubMed ID: 29233015
[TBL] [Abstract][Full Text] [Related]
26. Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles.
Wang H; Sun S; Zhang Y; Wang J; Zhang S; Yao X; Chen L; Gao Z; Xie B
Drug Deliv; 2019 Dec; 26(1):89-97. PubMed ID: 30744448
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
28. The effect of phospho-peptide on the stability of gold nanoparticles and drug delivery.
Hou Z; Wang Z; Liu R; Li H; Zhang Z; Su T; Yang J; Liu H
J Nanobiotechnology; 2019 Aug; 17(1):88. PubMed ID: 31426815
[TBL] [Abstract][Full Text] [Related]
29. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Guo J; O'Driscoll CM; Holmes JD; Rahme K
Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery.
Cheng MJ; Prabakaran P; Kumar R; Sridhar S; Ebong EE
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364277
[TBL] [Abstract][Full Text] [Related]
31. Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release.
Chen X; Han W; Zhao X; Tang W; Wang F
Sci Rep; 2019 May; 9(1):6754. PubMed ID: 31043709
[TBL] [Abstract][Full Text] [Related]
32. Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers.
Zhao L; Kim TH; Kim HW; Ahn JC; Kim SY
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():611-622. PubMed ID: 27287160
[TBL] [Abstract][Full Text] [Related]
33. Self-assembly of biogenic gold nanoparticles and their use to enhance drug delivery into cells.
Seo JM; Kim EB; Hyun MS; Kim BB; Park TJ
Colloids Surf B Biointerfaces; 2015 Nov; 135():27-34. PubMed ID: 26241913
[TBL] [Abstract][Full Text] [Related]
34. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.
Liang X; Fan J; Zhao Y; Cheng M; Wang X; Jin R; Sun T
J Biomater Appl; 2017 Apr; 31(9):1247-1256. PubMed ID: 28350205
[TBL] [Abstract][Full Text] [Related]
35. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
36. Antidiabetic assessment; in vivo study of gold and core-shell silver-gold nanoparticles on streptozotocin-induced diabetic rats.
Shaheen TI; El-Naggar ME; Hussein JS; El-Bana M; Emara E; El-Khayat Z; Fouda MMG; Ebaid H; Hebeish A
Biomed Pharmacother; 2016 Oct; 83():865-875. PubMed ID: 27505864
[TBL] [Abstract][Full Text] [Related]
37. Gold nanoparticle-based drug delivery platform for antineoplastic chemotherapy.
Liang JJ; Zhou YY; Wu J; Ding Y
Curr Drug Metab; 2014; 15(6):620-31. PubMed ID: 24909418
[TBL] [Abstract][Full Text] [Related]
38. Confocal Raman microspectroscopic study of folate receptor-targeted delivery of 6-mercaptopurine-embedded gold nanoparticles in a single cell.
Park J; Jeon WI; Lee SY; Ock KS; Seo JH; Park J; Ganbold EO; Cho K; Song NW; Joo SW
J Biomed Mater Res A; 2012 May; 100(5):1221-8. PubMed ID: 22359274
[TBL] [Abstract][Full Text] [Related]
39. An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer.
Thambiraj S; Hema S; Shankaran DR
Recent Pat Nanotechnol; 2018; 12(2):110-131. PubMed ID: 29090672
[TBL] [Abstract][Full Text] [Related]
40. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study.
Venkatpurwar V; Shiras A; Pokharkar V
Int J Pharm; 2011 May; 409(1-2):314-20. PubMed ID: 21376108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
